OleanderPhase I Clinical Trial of PBI-05204 successfully completed at M. D. Anderson Cancer Center. Posted on May 2011June 2022 by Carlos Torres 06 May Phoenix Biotechnology executes a fifth amendment to its Sponsored Research Agreement with M. D. Anderson Cancer Center. Phoenix Biotechnology executes a sixth amendment to its Sponsored Research Agreement with M. D. Anderson Cancer Center.
